Ovarian cancer recurrent – Life with Disease

Go back

Recurrent ovarian cancer refers to cancer that has returned after a period of remission or no evidence of disease. While learning that cancer has come back can be frightening and overwhelming, it’s important to know that treatment options continue to advance, and many people are able to manage this condition and maintain quality of life for years.

Understanding the Prognosis

When ovarian cancer returns, it is important to understand that while recurrent ovarian cancer is treatable, it is rarely completely curable. However, this does not mean that hope is lost. Advances in therapies now allow many individuals to manage recurrent ovarian cancer as a chronic illness—a condition that requires ongoing treatment and monitoring but can be controlled for extended periods.[1]

The outlook after recurrence varies widely from person to person. Several factors can influence your prognosis, including your age at the time of initial surgery, how much time passed between the end of your first treatment and the recurrence, how much tumor was successfully removed during your initial surgery, and how well your body responded to the combination of surgery, chemotherapy, and other treatments.[2] Younger individuals and those who experience a longer gap between treatment and recurrence often have a better outlook.

Statistics suggest that the median time people live after an ovarian cancer recurrence is approximately two years. However, these numbers are broad estimates and do not predict what will happen in your individual case.[2] Every person’s situation is unique, and your doctor can provide a more personalized understanding of your outlook based on your specific characteristics and circumstances.

⚠️ Important
Statistics are broad representations and do not dictate personal outcomes. Your individual experience will depend on many factors unique to you, including the stage at which your cancer was first diagnosed, the type of ovarian cancer you have, and your overall health. Always discuss your personal prognosis with your healthcare team.

The five-year relative survival rate varies depending on the type of ovarian cancer. For epithelial ovarian cancer—cancer that begins in the cells covering the outer surface of the ovaries—the five-year relative survival rate is about 50 percent. For stromal cancer, which develops in the connective tissue cells of the ovaries, the rate is 89 percent. For germ cell tumors, which arise from the cells that make eggs, it is 92 percent.[2] Recurrent ovarian cancer typically has lower overall survival rates compared to initial diagnoses, but remember that these are averages and not predictions for any one person.

Natural Progression Without Treatment

If recurrent ovarian cancer is left untreated, the disease will continue to grow and spread. The cancer may remain localized in the pelvis and abdominal cavity, or it may spread to distant areas of the body. This spread can affect multiple organs and systems, leading to a worsening of symptoms and a decline in overall health.[4]

Without treatment, the cancer cells multiply more rapidly, and tumors may grow larger. This can lead to increased pressure on surrounding organs, blockages in the digestive system, and the accumulation of fluid in the abdomen, known as ascites. The body’s ability to function normally becomes compromised as the disease progresses.

The timeline of progression varies widely. Some individuals may experience rapid growth of the cancer within weeks, while others may have slower progression over months. However, without intervention, the disease will eventually lead to severe complications and a shortened lifespan. This is why working with your healthcare team to explore treatment options is so important.

Possible Complications

Recurrent ovarian cancer can bring about several complications that may affect your health and quality of life. One of the most common and serious complications is bowel obstruction, which occurs when the cancer sits on or presses against the bowels, preventing normal movement of food and waste through the digestive system. This can cause nausea, vomiting, severe abdominal pain, and the inability to have a bowel movement.[14] If you experience these symptoms, it is crucial to seek medical attention immediately, as bowel obstruction can be life-threatening.

Other complications include the buildup of fluid in the abdomen, which can cause bloating, discomfort, and difficulty breathing. This fluid accumulation, called ascites, can become quite pronounced and may require drainage procedures to provide relief.

Pain is another common complication. As the cancer grows and spreads, it can press on nerves, organs, and tissues, causing persistent pain in the abdomen, pelvis, or lower back. Some individuals also experience pain during bowel movements or urination.[6]

Fatigue is a nearly universal complication of recurrent ovarian cancer. The disease itself, combined with the treatments used to manage it, can leave you feeling exhausted even after rest. Sleep problems are also common, as physical discomfort, anxiety, and medication side effects can all interfere with restful sleep.[2]

Additionally, recurrent cancer can lead to weight loss and loss of appetite. Nausea, changes in taste, and early feelings of fullness can make it difficult to maintain adequate nutrition. This, in turn, can weaken the body and make it harder to tolerate treatments.

⚠️ Important
Bowel obstruction is a medical emergency. If you cannot have a bowel movement and experience nausea, vomiting, or severe abdominal pain, contact your healthcare team immediately or go to the nearest emergency room. Early intervention can prevent more serious complications.

Impact on Daily Life

Living with recurrent ovarian cancer affects nearly every aspect of daily life. Physically, the disease and its treatments can leave you feeling tired, weak, and uncomfortable. Simple tasks that once felt effortless—like cooking a meal, cleaning the house, or running errands—may now require more energy and planning than you have available.[14]

Many individuals experience long-term side effects from chemotherapy and other treatments. Peripheral neuropathy—numbness and tingling in the fingers and toes—can make it difficult to perform tasks that require fine motor skills, such as buttoning a shirt or typing on a keyboard. Muscle and joint aches, weak legs, and ongoing bowel or bladder issues can further limit your physical abilities. It can take a full year or more to recover from chemotherapy, and some side effects, like peripheral neuropathy, may be permanent.[14]

Emotionally, the impact can be just as profound. The fear of recurrence—or of another recurrence—is a common source of anxiety. You may find yourself worrying about test results, interpreting every new symptom as a sign that the cancer is spreading, or feeling uncertain about the future. Feelings of sadness, frustration, guilt, and exhaustion are normal and valid.[14] It is important to honor these emotions and to reach out for support when you need it.

Socially, recurrent ovarian cancer can change your relationships and interactions. You may find it harder to participate in social activities, either because of physical limitations or because you simply do not have the energy. Friends and family members may not know how to help or what to say, which can lead to feelings of isolation. On the other hand, some relationships may deepen as loved ones step up to provide support and companionship.

Work life can also be affected. Depending on the severity of your symptoms and the demands of your treatment schedule, you may need to reduce your hours, take a leave of absence, or stop working altogether. This can bring financial stress as well as a sense of loss if your work has been an important part of your identity.

Hobbies and activities that once brought you joy may need to be adjusted. You might not be able to engage in physically demanding hobbies, but you may find new ways to enjoy your interests. For example, if you loved gardening, you might focus on container gardening that requires less bending and lifting. If you enjoyed cooking, you might invite a friend to help you prepare simpler meals.

Coping strategies can help you navigate these challenges. Setting small, achievable goals each day can give you a sense of control and accomplishment. Reaching out to support groups—whether in person or online—can connect you with others who understand what you are going through. Practicing relaxation techniques, such as deep breathing or meditation, can help manage anxiety. And most importantly, communicating openly with your healthcare team about your symptoms and concerns can lead to better symptom management and improved quality of life.[14]

Support for Family and Understanding Clinical Trials

If you have a loved one with recurrent ovarian cancer, your support can make a tremendous difference. One of the most important ways you can help is by learning about the disease and the treatment options available, including clinical trials. Clinical trials are research studies that test new treatments or therapies for cancer. They may provide access to promising new treatments that are not yet widely available.[16]

As a family member or caregiver, you can assist by helping to research clinical trials that may be appropriate for your loved one. Talk to the healthcare team about whether a clinical trial might be a good option. Ask about the potential benefits and risks, what the trial involves, and how it fits into the overall treatment plan. Many clinical trials are looking for participants, and your loved one may be eligible even if previous treatments have not been successful.[16]

Beyond clinical trials, there are many practical ways to support someone with recurrent ovarian cancer. Accompany them to doctor’s appointments and take notes so they can focus on the conversation. Help them keep track of medications, appointments, and symptoms. Assist with daily tasks like meal preparation, housework, and transportation. Simply being present and listening without judgment can provide immense emotional comfort.

It is also important to encourage your loved one to seek professional support. A therapist or counselor who specializes in cancer care can help them process their emotions and develop coping strategies. Support groups—both for patients and for caregivers—can provide a sense of community and understanding.[16]

Remember to take care of yourself as well. Caregiving can be physically and emotionally exhausting. Make time for your own health and well-being, and do not hesitate to ask for help from other family members, friends, or community resources.

💊 Registered drugs used for this disease

List of officially registered medicines that are used in the treatment of recurrent ovarian cancer, based only on the provided sources:

  • Carboplatin – A type of platinum chemotherapy drug commonly used in initial treatment and may be used again if the cancer recurs more than six months after the last treatment.
  • Paclitaxel – A chemotherapy drug often used in combination with carboplatin or on its own, particularly as a weekly treatment for platinum-resistant cancer.
  • Liposomal doxorubicin – A chemotherapy drug used in combination with other treatments for recurrent ovarian cancer.
  • Gemcitabine – A chemotherapy drug used in combination with carboplatin or as a single agent for platinum-resistant recurrence.
  • Topotecan – A chemotherapy drug used for platinum-resistant recurrent ovarian cancer.
  • Etoposide – A chemotherapy drug that may be used for platinum-resistant recurrence.
  • Cyclophosphamide – A chemotherapy drug that may be used for platinum-resistant recurrence.
  • PARP inhibitors – Maintenance medications given to patients after chemotherapy, particularly those with BRCA mutations, to help keep the cancer in remission for up to two years.

Ongoing Clinical Trials on Ovarian cancer recurrent

  • Study of ubamatamab alone or with cemiplimab for adults with ovarian, fallopian tube, peritoneal, or endometrial cancer that has come back

    Recruiting

    2 1 1 1
    Belgium France Italy The Netherlands Spain
  • Study of Sacituzumab Tirumotecan and Bevacizumab for Patients with Recurrent Ovarian Cancer

    Recruiting

    3 1 1 1
    Austria Belgium Czechia Denmark Finland France +8
  • Study of Olaparib for Patients with Recurrent Ovarian Cancer Without BRCA Gene Mutations

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy
  • Study on zAvatar Test for Treatment Decisions in Relapsed Ovarian Cancer and Metastatic Breast Cancer Using Palbociclib and Drug Combination for Eligible Patients

    Recruiting

    3 1 1 1
    Portugal
  • Study on the Safety and Effectiveness of REGN5668 with Cemiplimab or Ubamatamab for Patients with Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

    Recruiting

    2 1 1 1
    Belgium France Spain
  • Study of DS-3939a for Patients with Advanced or Metastatic Solid Tumors

    Recruiting

    2 1 1
    Investigated drugs:
    Belgium France Spain
  • Study of Azenosertib and Niraparib for Patients with Platinum-Resistant Ovarian Cancer

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    France
  • Study of Avutometinib and Defactinib for Patients with Recurrent Low-Grade Serous Ovarian Cancer

    Not recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium France Italy Spain
  • Study of Pembrolizumab and Chemotherapy for Patients with Recurrent Platinum-Sensitive Low-Grade Serous Ovarian Cancer

    Not recruiting

    2 1 1 1
    Investigated drugs:
    Germany
  • Study of Pertuzumab and Trastuzumab for Patients with Solid Malignant Tumors from Previous Pertuzumab Trials

    Not recruiting

    3 1 1 1
    Investigated drugs:
    Italy Portugal Spain

References

https://ocrahope.org/for-patients/recurrence/

https://www.myovariancancerteam.com/resources/recurrent-ovarian-cancer-explained

https://pmc.ncbi.nlm.nih.gov/articles/PMC7475365/

https://www.cancerresearchuk.org/about-cancer/ovarian-cancer/treatment/if-your-cancer-comes-back

https://ovarian.org/ovarian-cancer-patients/ovarian-cancer-recurrence/

https://www.medicalnewstoday.com/articles/ovarian-cancer-recurrence

https://www.webmd.com/ovarian-cancer/ovarian-cancer-recurrence-what-to-know

https://www.roswellpark.org/cancertalk/202311/what-if-my-ovarian-cancer-comes-back

https://pmc.ncbi.nlm.nih.gov/articles/PMC2801501/

https://www.cancerresearchuk.org/about-cancer/ovarian-cancer/treatment/if-your-cancer-comes-back

https://pubmed.ncbi.nlm.nih.gov/29232464/

https://ocrahope.org/for-patients/recurrence/

https://www.myovariancancerteam.com/resources/recurrent-ovarian-cancer-explained

https://cancerblog.mayoclinic.org/2023/10/04/life-after-ovarian-cancer-coping-with-side-effects-fear-of-recurrence-and-finding-support/

https://www.cancer.gov/news-events/cancer-currents-blog/2022/ovarian-cancer-return-surgery-desktop-iii

https://ovarian.org/first-steps-ovarian-cancer-recurrence/

https://ovarian.org/first-steps-ovarian-cancer-recurrence/

https://cancerblog.mayoclinic.org/2023/10/04/life-after-ovarian-cancer-coping-with-side-effects-fear-of-recurrence-and-finding-support/

https://ocrahope.org/news/ovarian-cancer-recurrence-inspired-advice/

https://ourwayforward.com/ovarian-cancer/living-with-ovarian-cancer/

https://www.myovariancancerteam.com/resources/recurrent-ovarian-cancer-explained

https://blog.virginiacancer.com/what-to-expect-after-completing-ovarian-cancer-treatment

https://www.cancer.org/cancer/types/ovarian-cancer/after-treatment.html

https://medlineplus.gov/diagnostictests.html

https://www.questdiagnostics.com/

https://www.healthdirect.gov.au/diagnostic-tests

https://www.who.int/health-topics/diagnostics

https://www.yalemedicine.org/clinical-keywords/diagnostic-testsprocedures

https://www.nibib.nih.gov/science-education/science-topics/rapid-diagnostics

https://www.health.harvard.edu/diagnostic-tests-and-medical-procedures

https://www.roche.com/stories/terminology-in-diagnostics

FAQ

How likely is ovarian cancer to come back after treatment?

The likelihood of recurrence depends heavily on the stage of cancer at initial diagnosis. For Stage 1, there is a 10 percent chance of recurrence. For Stage 2, the chance is 30 percent. For Stage 3, the chance rises to 70 to 90 percent, and for Stage 4, it is 90 to 95 percent. Overall, approximately 70 to 80 percent of individuals treated for ovarian cancer will experience a recurrence at some point.

What are the symptoms of recurrent ovarian cancer?

Symptoms of recurrent ovarian cancer may be similar to the original cancer symptoms or may be different. Common symptoms include fatigue, sleeping problems, pain, abdominal pain, swelling or bloating, nausea, changes in bowel movements, pelvic or lower back pain, and urinary issues. If you experience any of these symptoms, especially if they are new or worsening, contact your healthcare team.

Can recurrent ovarian cancer be cured?

Recurrent ovarian cancer is treatable but is rarely completely curable. However, advances in therapies allow many people to manage it as a chronic illness, controlling the disease for years and maintaining quality of life. Treatment focuses on shrinking the cancer, controlling it for as long as possible, and managing symptoms.

What treatment options are available for recurrent ovarian cancer?

Treatment options depend on several factors, including the type of ovarian cancer, where the cancer is in your body, what treatments you have already had, when you last had treatment, and your overall health. Options may include chemotherapy with drugs like carboplatin, paclitaxel, liposomal doxorubicin, or gemcitabine; surgery to remove tumors; targeted cancer drugs such as PARP inhibitors; hormone therapy; and participation in clinical trials testing new treatments.

When does ovarian cancer typically recur?

Recurrent ovarian cancer is most likely to come back within 16 to 21 months after initial treatment ends. However, recurrence can technically happen at any time, from weeks after treatment to several years later. The timing depends on factors such as how aggressive the cancer is and how well it responded to initial treatment.

🎯 Key takeaways

  • Recurrent ovarian cancer affects 70 to 80 percent of people treated for the disease, but it can often be managed as a chronic condition with ongoing treatment.
  • The stage of cancer at initial diagnosis significantly influences recurrence risk, with early-stage cancers having much lower recurrence rates than advanced-stage cancers.
  • Statistics are helpful for understanding general trends, but they do not predict individual outcomes—your experience will be unique to you.
  • Bowel obstruction is a serious complication of recurrent ovarian cancer that requires immediate medical attention if you cannot have a bowel movement and experience nausea or vomiting.
  • Long-term side effects from chemotherapy, such as peripheral neuropathy and fatigue, can persist for months or even years and may affect your daily activities and quality of life.
  • Clinical trials offer access to promising new treatments and are an important option to consider, particularly if previous treatments have not been successful.
  • Emotional support from family, friends, therapists, and support groups can make a significant difference in coping with the fear, anxiety, and uncertainty that comes with recurrence.
  • Open communication with your healthcare team about symptoms, side effects, and concerns is essential for effective symptom management and improved quality of life.